This announcement is a separate document:
海思科:关于获得创新药HSK42360片《药物临床试验批准通知书》的公告
Haisco Pharmaceutical Group: Announcement regarding the approval notice for clinical trial of innovative drug HSK42360 tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.